Lv1
100 积分 2025-08-15 加入
Optimal two-stage designs for phase II clinical trials
3个月前
已完结
追踪国外六大监管机构获批药品在中国的可及性
3个月前
已关闭
论药品监管指导原则的法律渊源与法律运用
3个月前
已完结
小分子药物研发中代谢产物非临床研究的关注要点
3个月前
已完结
An FDA oncology analysis of antibody-drug conjugates
4个月前
已完结
The Retrofit: Lessons From Sotorasib's Dosing Conundrum
4个月前
已完结
Consideration of the biosimilar drug lag and loss among Japan, the USA, and the EU
5个月前
已完结
Survey on the Role of Comparative Efficacy Studies Required for Biosimilar Monoclonal Antibody Approval in Japan to Justify the Quality Attribute Differences Between Biosimilars and Their Reference Products Based on the Pharmaceuticals and Medical Devices Agency (PMDA) Assessments
5个月前
已完结
皖公网安备34019202002308
